None listed
Conditions
Interventions
Medical Device, Procedure/Surgery : 1. Intervention Name: Electroacupuncture Treatment (1 session per visit, total 2 sessions, 2Hz frequency, continuous wave, 15-minute needling, with the current at t
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The following criteria must be met for inclusion: 1) Adults aged 19 to 80 years, both male and female 2) Diagnosed with cancer stages 1 to 4 (ICD codes: C00–C97) 3) Experiencing continuous cancer pain for the past 3 months with a Numerical Rating Scale (NRS) of 4 or higher at the time of visit 4) Able to understand the purpose and procedures of this clinical trial, respond to pain questionnaires, and voluntarily sign the informed consent form
Exclusion criteria
Exclusion criteria: Participants will be excluded from this clinical trial if they meet any of the following exclusion criteria: 1) Pain is not consistent with the definition of cancer pain 2) Pregnant or breastfeeding women 3) Received acupuncture or electroacupuncture treatment within 7 days prior to the screening visit 4) Participated in another clinical trial with an intervention (e.g., medication, acupuncture, electroacupuncture) within 1 month prior to the screening visit, or are currently participating, or have cancer surgery, chemotherapy, or radiation therapy scheduled within the next 2 weeks 5) Known hypersensitivity or risk of adverse reactions to acupuncture, electroacupuncture, or transcutaneous nerve stimulation therapy 6) Malignant skin tumors, severe infectious conditions (e.g., cellulitis), or severe edema due to deep vein thrombosis at the acupuncture site 7) History of alcohol addiction, major depressive disorder, schizophrenia, bipolar disorder, or other uncontrolled serious neuropsychiatric conditions 8) Any other reason deemed by the principal investigator to make participation in the clinical trial difficult
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer pain intensity questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| Cancer pain intensity and pain characteristics questionnaire;Pain questionnaire for the past 24 hours;Heart rate variability (HRV) parameters collected from the heart rate variability measurement device.;Pulse diagnostic parameters collected from the pulse measurement device.;Activity data collected from the smart band | — |
Countries
Korea, Republic of
Contacts
Public ContactDong-Hyeon Kim
Pusan National University Korean Medicine Hospital
Outcome results
None listed